HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anti-Ri-associated paraneoplastic cerebellar degeneration without opsoclonus in a patient with a neuroendocrine carcinoma of the stomach.

Abstract
We report a case of a 63-year-old man suffering from anti-Ri-associated paraneoplastic cerebellar degeneration (PCD) with gastric cancer. The neurologic presentation was limited to severe cerebellar ataxia without opsoclonus. The gastric cancer was composed of both poorly differentiated adenocarcinoma and neuro-endocrine carcinoma. The patient's serum reacted with recombinant Ri antigen and the neuroendocrine tumor component. It is thus considered that PCD without opsoclonus in the present case was related to the gastric neuroendocrine tumor and anti-Ri antibody.
AuthorsH Kikuchi, T Yamada, A Okayama, H Hara, T Taniwaki, H Shigeto, M Sasaki, T Iwaki, J Kira
JournalFukuoka igaku zasshi = Hukuoka acta medica (Fukuoka Igaku Zasshi) Vol. 91 Issue 4 Pg. 104-9 (Apr 2000) ISSN: 0016-254X [Print] Japan
PMID10826224 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antigens, Neoplasm
  • Autoantibodies
  • Biomarkers
  • Nerve Tissue Proteins
  • Neuro-Oncological Ventral Antigen
  • RNA-Binding Proteins
Topics
  • Adenocarcinoma (complications)
  • Antigens, Neoplasm (immunology)
  • Autoantibodies (blood)
  • Biomarkers (blood)
  • Carcinoma, Neuroendocrine (complications)
  • Cerebellar Ataxia (etiology)
  • Humans
  • Male
  • Middle Aged
  • Neoplasms, Multiple Primary
  • Nerve Tissue Proteins
  • Neuro-Oncological Ventral Antigen
  • Ocular Motility Disorders
  • Paraneoplastic Cerebellar Degeneration (diagnosis, etiology)
  • RNA-Binding Proteins
  • Stomach Neoplasms (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: